Galvin Gaustad & Stein LLC Grows Position in HCA Healthcare, Inc. $HCA

Key Points

• Galvin Gaustad & Stein LLC increased its stake in HCA Healthcare, Inc. by 7.4% in the second quarter, bringing its total holdings to 83,921 shares valued at approximately $32.15 million.
• HCA Healthcare recently reported earnings of $6.84 per share for the last quarter, exceeding analysts' expectations, and its quarterly revenue increased by 6.4% year-over-year.
• The company announced a quarterly dividend of $0.72 per share, with a total annualized dividend of $2.88 and a yield of 0.7%.

Galvin Gaustad & Stein LLC grew its position in HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 7.4% during the second quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 83,921 shares of the company's stock after buying an additional 5,814 shares during the period. HCA Healthcare accounts for about 2.8% of Galvin Gaustad & Stein LLC's portfolio, making the stock its 4th largest position. Galvin Gaustad & Stein LLC's holdings in HCA Healthcare were worth $32,150,000 at the end of the most recent reporting period.

A number of other institutional investors also recently bought and sold shares of the stock. Price T Rowe Associates Inc. MD boosted its stake in HCA Healthcare by 83.4% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 2,399,372 shares of the company's stock worth $829,104,000 after purchasing an additional 1,091,416 shares in the last quarter. Goldman Sachs Group Inc. lifted its stake in HCA Healthcare by 49.1% during the 1st quarter. Goldman Sachs Group Inc. now owns 1,781,459 shares of the company's stock valued at $615,583,000 after acquiring an additional 587,036 shares during the period. Nuveen LLC acquired a new stake in HCA Healthcare during the 1st quarter valued at approximately $569,217,000. Pacer Advisors Inc. lifted its stake in HCA Healthcare by 6,237.9% during the 1st quarter. Pacer Advisors Inc. now owns 1,350,933 shares of the company's stock valued at $466,815,000 after acquiring an additional 1,329,618 shares during the period. Finally, Principal Financial Group Inc. lifted its stake in HCA Healthcare by 0.8% during the 1st quarter. Principal Financial Group Inc. now owns 880,663 shares of the company's stock valued at $304,313,000 after acquiring an additional 6,888 shares during the period. 62.73% of the stock is currently owned by institutional investors and hedge funds.

HCA Healthcare Trading Down 1.9%

Shares of HCA opened at $418.35 on Friday. HCA Healthcare, Inc. has a 12-month low of $289.98 and a 12-month high of $439.01. The firm has a 50-day moving average price of $403.96 and a 200 day moving average price of $375.04. The firm has a market capitalization of $97.89 billion, a P/E ratio of 17.59, a P/E/G ratio of 1.34 and a beta of 1.40.

HCA Healthcare (NYSE:HCA - Get Free Report) last announced its quarterly earnings data on Friday, July 25th. The company reported $6.84 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $6.20 by $0.64. The firm had revenue of $18.61 billion during the quarter, compared to analyst estimates of $18.49 billion. HCA Healthcare had a net margin of 8.21% and a negative return on equity of 7,363.11%. HCA Healthcare's quarterly revenue was up 6.4% on a year-over-year basis. During the same quarter in the prior year, the firm posted $5.50 earnings per share. HCA Healthcare has set its FY 2025 guidance at 25.500-27.000 EPS. Equities research analysts predict that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, September 30th. Shareholders of record on Tuesday, September 16th were paid a dividend of $0.72 per share. This represents a $2.88 annualized dividend and a yield of 0.7%. The ex-dividend date of this dividend was Tuesday, September 16th. HCA Healthcare's dividend payout ratio (DPR) is 12.11%.

Insider Activity at HCA Healthcare

In other news, EVP Michael S. Cuffe sold 3,836 shares of the firm's stock in a transaction that occurred on Monday, September 8th. The shares were sold at an average price of $418.84, for a total value of $1,606,670.24. Following the completion of the transaction, the executive vice president owned 31,503 shares of the company's stock, valued at approximately $13,194,716.52. This trade represents a 10.85% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Insiders own 1.30% of the company's stock.

Wall Street Analyst Weigh In

HCA has been the subject of several recent research reports. Wolfe Research lowered shares of HCA Healthcare from an "outperform" rating to a "peer perform" rating in a report on Monday, July 28th. UBS Group set a $465.00 target price on shares of HCA Healthcare in a report on Wednesday. JPMorgan Chase & Co. boosted their price target on shares of HCA Healthcare from $360.00 to $370.00 and gave the stock a "neutral" rating in a report on Monday, August 4th. Weiss Ratings reissued a "buy (b-)" rating on shares of HCA Healthcare in a report on Wednesday. Finally, Wells Fargo & Company boosted their price target on shares of HCA Healthcare from $375.00 to $412.00 and gave the stock an "equal weight" rating in a report on Tuesday. One investment analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating and nine have issued a Hold rating to the stock. According to MarketBeat, HCA Healthcare presently has an average rating of "Moderate Buy" and an average target price of $422.31.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCA - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.